Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2026)

Updated

Adaptin Bio (APTN) recorded Other Accumulated Expenses of $25,000 in Q4 2025.

Analysis

Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2026) Analysis & Trends

Starting with Q4 2022, Adaptin Bio's Other Accumulated Expenses history includes 7 quarters.

  • Annual Other Accumulated Expenses has a three-year compound annual growth rate of 18.6% (FY2022 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $64,000 in FY2023 (+326.7%) and $15,000 in FY2022.
  • The Q4 2025 figure is the highest quarterly Other Accumulated Expenses since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 446,740.00
Dec 31, 2025 25,000.00
Sep 30, 2025 16,195.00
Jun 30, 2025 429,449.00
Mar 31, 2025 12,576.00
Dec 31, 2024 968,130.00
Sep 30, 2024 44,750.00
Jun 30, 2024 40,500.00
Mar 31, 2024 36,250.00
Dec 31, 2023 64,000.00
Sep 30, 2023 27,750.00
Dec 31, 2022 15,000.00
API Access

Adaptin Bio Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=APTN&period=max&api_key=YOUR_API_KEY